I was watching the 2011 IHRF patient conference proceedings on DVD. They're available in the IHRF online store.
http://www.ihrfoundation.org/intracranial/hypertension/store/C79
Anyway, during one of the sessions Dr. Katz from Ohio State Univ. said that he isn't prescribing as much Octreotide as he used to, due to insurance companies no longer covering it, and a success rate that isn't as high as the greek study.
Does anybody in here have more information on this? For me it's either Octreotide or neurosurgery. It's a no-brainer which one to try first, but I need all the facts. Or at least whatever information people's neurologists have told them. Anyone have knowlege to share?
BTW, brand name Sandostatin (octreotide) is about $10K/month! Eeek!